Phm bolsa

Looking for more advanced features?

Add to a list Add to a list. To use this feature you must be a member. Pharma Mar, S. Real-time Estimate Tradegate Other stock markets. Funds and ETFs.

Phm bolsa

PharmaMar is a biopharmaceutical company focused on the research and development of new oncology treatments, whose mission is to improve the healthcare outcomes of patients afflicted by serious diseases with our innovative medicines. The Company is inspired by the sea, driven by science, and motivated by patients with serious diseases to improve their lives by delivering novel medicines to them. PharmaMar intends to continue to be the world leader in marine medicinal discovery, development and innovation. PharmaMar has other clinical-stage programs under development for several types of solid cancers: lurbinectedin, ecubectedin, PM and PM It also has a preclinical and clinical program in virology. PharmaMar also wholly owns Sylentis, a company dedicated to researching therapeutic applications of gene silencing RNAi. To obtain detailed information or information in other formats, please contact BME Market Data at marketdata grupobme. The information provided by the different websites of Grupo BME is for internal use only. Please contact us at marketdata grupobme. Profile PharmaMar is a biopharmaceutical company focused on the research and development of new oncology treatments, whose mission is to improve the healthcare outcomes of patients afflicted by serious diseases with our innovative medicines.

Transcript : Pharma Mar, S.

.

Pharma Mar, S. About the company. The company operates through Oncology and RNA interference segments. Earnings are forecast to grow High level of non-cash earnings. Profit margins 0. New major risk - Dividend sustainability Mar Price target decreased by 9.

Phm bolsa

Add to a list Add to a list. To use this feature you must be a member. Pharma Mar, S. Funds and ETFs. Chart Pharma Mar, S. Duration 1 day 1 week 1 month 3 months 6 months 1 year 5 years 10 years. Period 5 minutes 15 minutes 30 minutes 1 hour 1 day 1 week 1 month 1 year. Latest news about Pharma Mar, S. Transcript : Pharma Mar, S.

Bluebay hotels wikipedia

Discover in video Backtesting and optimisation Test and optimize your trading strategies before using them in real markets. Looking for more advanced features? Chart Pharma Mar, S. PharmaMar receives approval of Zepzelca for the treatment of metastatic small cell lung cancer in Macau, China. Pharma Mar, S. Press releases Pharma Mar, S. EPS Revisions. The Company is active globally. Market replay Practice trading on past data, on any instrument, in any time frame. Attach orders to alerts Attach your entry or exit orders to alerts so they are automatically executed when your alert is triggered. Profile PharmaMar is a biopharmaceutical company focused on the research and development of new oncology treatments, whose mission is to improve the healthcare outcomes of patients afflicted by serious diseases with our innovative medicines.

.

Display up to 20 simultaneous charts across one or several monitors. Looking for more advanced features? Learn more 1. Market replay Practice trading on past data, on any instrument, in any time frame. PharmaMar also wholly owns Sylentis, a company dedicated to researching therapeutic applications of gene silencing RNAi. Duration 1 day 1 week 1 month 3 months 6 months 1 year 5 years 10 years. Sector Biopharmaceuticals. PharmaMar receives a payment of 10 million dollars from Janssen as a commercial milestone. PharmaMar intends to continue to be the world leader in marine medicinal discovery, development and innovation. Press releases Pharma Mar, S. Attach your entry or exit orders to alerts so they are automatically executed when your alert is triggered.